Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 84 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 1661

Topic: Biology, Genetics & Bone Healing

Aseptic loosening in total joint arthroplasty is largely driven by a biologic reaction to wear debris. Which of the following is the most critical primary effector cell responsible for phagocytosing submicron polyethylene particles and subsequently releasing osteolytic cytokines such as TNF-alpha and IL-1?

. Osteoblasts
. Osteoclasts
. Macrophages
. T lymphocytes
. Fibroblasts

Correct Answer & Explanation

. Macrophages

Explanation

Macrophages are the primary cellular drivers of particle-induced osteolysis in aseptic loosening. They phagocytose wear debris particles (most reactively between 0.1 to 1.0 micrometers in size). Unable to digest the polyethylene, they become activated and secrete pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6, PGE2), which upregulate RANKL expression and subsequently stimulate osteoclast-mediated periprosthetic bone resorption.

Question 1662

Topic: Biology, Genetics & Bone Healing

A 68-year-old woman with a T-score of -3.2 at the femoral neck and a history of a distal radius fracture is prescribed romosozumab. This medication is a humanized monoclonal antibody designed to increase bone mineral density. What is the primary molecular mechanism of action of this pharmacological agent?

. Binding to RANKL to prevent osteoclastogenesis and induce osteoclast apoptosis
. Direct agonism of the calcium-sensing receptor on the parathyroid gland
. Inhibition of the Wnt/beta-catenin signaling pathway to prevent bone resorption
. Prevention of sclerostin-mediated inhibition of the Wnt/beta-catenin signaling pathway
. Acting as a decoy receptor for interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-a)

Correct Answer & Explanation

. Prevention of sclerostin-mediated inhibition of the Wnt/beta-catenin signaling pathway

Explanation

Romosozumab is a monoclonal antibody that binds to and neutralizes sclerostin. Sclerostin is a glycoprotein secreted primarily by osteocytes that naturally inhibits osteoblastogenesis by binding to LRP5/6 receptors, thereby blocking the Wnt/beta-catenin signaling pathway. By neutralizing sclerostin, romosozumab disinhibits (activates) the Wnt/beta-catenin pathway, leading to a profound anabolic effect (increased bone formation) and a secondary antiresorptive effect. Denosumab binds to RANKL (Option A). Cinacalcet modulates the calcium-sensing receptor (Option B).

Question 1663

Topic: Biology, Genetics & Bone Healing
During the pathogenesis of osteoarthritis, the degradation of the articular cartilage extracellular matrix is driven by a cascade of proteolytic enzymes. While aggrecanases (such as ADAMTS-4 and ADAMTS-5) are responsible for early proteoglycan loss, which of the following enzymes is considered the primary mediator responsible for the irreversible cleavage and destruction of Type II collagen?
. Matrix metalloproteinase-1 (MMP-1)
. Matrix metalloproteinase-13 (MMP-13)
. Matrix metalloproteinase-3 (MMP-3)
. Cathepsin K
. Tissue inhibitor of metalloproteinases-1 (TIMP-1)

Correct Answer & Explanation

. Matrix metalloproteinase-13 (MMP-13)

Explanation

Matrix metalloproteinase-13 (MMP-13), also known as collagenase-3, is the primary enzyme responsible for the degradation of Type II collagen in osteoarthritic articular cartilage. Although MMP-1 (collagenase-1) also degrades collagen, MMP-13 is significantly more efficient at cleaving Type II collagen and is highly overexpressed in osteoarthritic cartilage. MMP-3 (stromelysin-1) degrades non-collagenous matrix proteins and activates other MMPs. Cathepsin K is the primary enzyme used by osteoclasts to degrade Type I collagen in bone. TIMPs are inhibitors of MMPs, and their relative deficiency contributes to OA progression.

Question 1664

Topic: Biology, Genetics & Bone Healing

A 72-year-old female with severe osteoporosis is treated with denosumab, a monoclonal antibody that targets RANKL. By blocking RANKL, this medication prevents the activation and maturation of osteoclasts. What natively produced physiological molecule performs an identical biological function by acting as a decoy receptor for RANKL?

. Osteocalcin
. Osteoprotegerin
. Macrophage colony-stimulating factor (M-CSF)
. Sclerostin
. Cathepsin K

Correct Answer & Explanation

. Osteoprotegerin

Explanation

Osteoprotegerin (OPG) is a glycoprotein naturally secreted by osteoblasts that acts as a soluble decoy receptor for RANKL. By binding to RANKL, OPG prevents RANKL from interacting with the RANK receptor on osteoclast precursors, thereby inhibiting osteoclastogenesis and reducing bone resorption. Denosumab mimics this exact mechanism therapeutically. Sclerostin is an inhibitor of the Wnt pathway. M-CSF promotes osteoclast precursor survival. Cathepsin K is an enzyme secreted by mature osteoclasts to degrade bone matrix.

Question 1665

Topic: Biology, Genetics & Bone Healing

A surgeon utilizes recombinant human bone morphogenetic protein-2 (rhBMP-2) on an absorbable collagen sponge to augment an anterior lumbar interbody fusion. Upon BMP-2 binding to its specific cell surface serine/threonine kinase receptors on mesenchymal stem cells, which of the following intracellular signaling pathways is primarily activated to promote osteoblastic differentiation?

. Wnt/beta-catenin pathway
. JAK/STAT pathway
. SMAD 1/5/8 pathway
. MAP kinase pathway
. Cyclic AMP/Protein kinase A pathway

Correct Answer & Explanation

. SMAD 1/5/8 pathway

Explanation

Bone morphogenetic proteins (BMPs) belong to the TGF-beta superfamily. When a BMP ligand binds to its transmembrane serine/threonine kinase receptor complex, it phosphorylates receptor-regulated SMADs, specifically SMAD 1, 5, and 8. These phosphorylated SMADs then form a complex with the co-SMAD (SMAD 4) and translocate to the nucleus to regulate the transcription of osteogenic genes like Runx2. The Wnt pathway uses beta-catenin.

Question 1666

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory, the phenotype of tissue that differentiates within a fracture gap is strictly dependent on the local interfragmentary strain. In order for primary (direct) bone healing with Haversian remodeling to occur without the intermediate formation of a visible fracture callus, the absolute interfragmentary strain must be kept below what critical threshold?

. 2%
. 10%
. 15%
. 50%
. 100%

Correct Answer & Explanation

. 2%

Explanation

Perren's strain theory states that tissues will not form if the local strain exceeds the maximum strain that tissue can withstand before rupturing. Granulation tissue tolerates up to 100% strain, fibrous tissue up to 17%, and fibrocartilage up to 10%. Bone tissue is highly brittle and can only withstand <2% strain. Therefore, primary (direct) bone healing—which bypasses callus formation—requires rigid fixation that maintains interfragmentary strain below 2%.

Question 1667

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction during fracture healing. Following the binding of a BMP (such as BMP-2) to its cell-surface serine/threonine kinase receptor, which of the following intracellular signaling molecules is directly phosphorylated to translocate to the nucleus and regulate gene transcription?

. Beta-catenin
. STAT3
. Smad 1/5/8
. NF-kappaB
. JAK2

Correct Answer & Explanation

. Smad 1/5/8

Explanation

BMPs bind to serine/threonine kinase receptors on the cell surface, leading to the phosphorylation of receptor-regulated Smads (Smad 1, 5, and 8). These phosphorylated Smads form a complex with the common-partner Smad (Smad 4) and translocate to the nucleus to regulate target gene transcription, promoting osteoblast differentiation (e.g., upregulating Runx2). Beta-catenin is involved in the Wnt signaling pathway, while NF-kappaB is downstream of RANKL.

Question 1668

Topic: Biology, Genetics & Bone Healing

A 55-year-old female with chronic kidney disease presents with secondary hyperparathyroidism. The persistently elevated levels of parathyroid hormone (PTH) have a profound effect on bone remodeling. Which of the following accurately describes the primary cellular mechanism by which PTH stimulates bone resorption?

. Direct binding of PTH to receptors on osteoclasts, leading to the release of cathepsin K
. Binding to receptors on osteoblasts, stimulating the expression of RANKL and decreasing the secretion of osteoprotegerin (OPG)
. Binding to receptors on osteocytes, inducing apoptosis and the subsequent recruitment of osteoclast precursors
. Direct stimulation of the renal hydroxylation of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D, which solely mediates osteoclast activation
. Inhibition of calcitonin secretion from the parafollicular C-cells of the thyroid, removing the inhibitory effect on osteoclasts

Correct Answer & Explanation

. Binding to receptors on osteoblasts, stimulating the expression of RANKL and decreasing the secretion of osteoprotegerin (OPG)

Explanation

Osteoclasts do not possess receptors for Parathyroid Hormone (PTH). Instead, PTH binds to specific receptors on osteoblasts, stimulating them to upregulate the expression of Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL) and downregulate the secretion of Osteoprotegerin (OPG), a decoy receptor. The increased RANKL binds to RANK on osteoclast precursors, driving their differentiation and activation into mature, active bone-resorbing osteoclasts.

Question 1669

Topic: Biology, Genetics & Bone Healing

A 72-year-old female with severe osteoporosis sustains a distal radius fracture. She is started on daily subcutaneous teriparatide to improve bone mass and potentially assist with fracture healing. Through which primary cellular mechanism does intermittent administration of this medication promote an anabolic effect on bone?

. Inhibition of osteoclast ruffled border formation via disruption of the mevalonate pathway
. Stimulation of Wnt/beta-catenin signaling via downregulation of sclerostin in osteocytes
. Direct inhibition of RANKL secretion by osteoblasts
. Activation of the calcium-sensing receptor on parafollicular C-cells
. Increased expression of osteoprotegerin (OPG) from bone marrow macrophages

Correct Answer & Explanation

. Stimulation of Wnt/beta-catenin signaling via downregulation of sclerostin in osteocytes

Explanation

Teriparatide is a recombinant human parathyroid hormone (PTH 1-34) analog. While continuous PTH exposure is catabolic, intermittent PTH administration is highly anabolic. It exerts its anabolic effect by increasing osteoblast lifespan (preventing apoptosis), stimulating osteoblast differentiation, and activating the Wnt/beta-catenin signaling pathway. A key part of this mechanism is the downregulation of sclerostin (a Wnt inhibitor encoded by the SOST gene) expressed by osteocytes.

Question 1670

Topic: Biology, Genetics & Bone Healing

A 35-year-old female presents with a destructive, eccentric, lytic lesion in the distal femur extending to the subchondral bone. Biopsy confirms a Giant Cell Tumor of Bone (GCTB). Due to the size and joint proximity, neoadjuvant denosumab is prescribed. Denosumab exerts its therapeutic effect in this condition by targeting which molecule, and which cell population primarily expresses this target?

. Targets RANK; expressed by the reactive multinucleated giant cells
. Targets RANKL; expressed by the neoplastic mononuclear stromal cells
. Targets Osteoprotegerin (OPG); expressed by the neoplastic mononuclear stromal cells
. Targets RANKL; expressed by the reactive multinucleated giant cells
. Targets Macrophage Colony-Stimulating Factor (M-CSF); expressed by osteoblasts

Correct Answer & Explanation

. Targets RANKL; expressed by the neoplastic mononuclear stromal cells

Explanation

Denosumab is a fully human monoclonal antibody that binds to and inhibits Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). In Giant Cell Tumor of Bone (GCTB), the neoplastic cells are actually the spindle-shaped mononuclear stromal cells. These stromal cells pathologically overexpress RANKL, which aggressively recruits and stimulates the formation of the reactive, non-neoplastic multinucleated giant cells (osteoclasts) responsible for the massive bone destruction. Thus, Denosumab targets RANKL secreted by the neoplastic mononuclear stromal cells.

Question 1671

Topic: Biology, Genetics & Bone Healing

A 45-year-old man undergoes a posterolateral lumbar fusion using recombinant human bone morphogenetic protein-2 (rhBMP-2). Upon binding to its specific cell surface receptor, which of the following intracellular signaling molecules is directly phosphorylated to propagate the osteoinductive signal?

. JAK
. STAT
. SMAD
. Beta-catenin
. NF-kappaB

Correct Answer & Explanation

. SMAD

Explanation

Bone morphogenetic proteins (BMPs) are members of the TGF-beta superfamily. When a BMP binds to its specific heterodimeric serine/threonine kinase receptor, it causes the intracellular phosphorylation of receptor-regulated SMADs (typically SMAD 1, 5, and 8). These phosphorylated SMADs then form a complex with a Co-SMAD (SMAD 4) and translocate to the nucleus to regulate the transcription of osteogenic genes, such as Runx2. Beta-catenin is involved in the Wnt signaling pathway. The JAK/STAT pathway is typically utilized by cytokines, and NF-kappaB is central to the RANKL pathway in osteoclasts.

Question 1672

Topic: Biology, Genetics & Bone Healing
A 28-year-old athlete undergoes an Achilles tendon repair. During the remodeling phase of tendon healing, the biomechanical strength of the tendon gradually increases. This process is primarily driven by the replacement of the initial scar tissue matrix with a more organized collagen structure. Which of the following best describes the predominant collagen transition during this phase?
. Type I collagen is replaced by Type II collagen
. Type I collagen is replaced by Type III collagen
. Type II collagen is replaced by Type X collagen
. Type III collagen is replaced by Type I collagen
. Type X collagen is replaced by Type I collagen

Correct Answer & Explanation

. Type III collagen is replaced by Type I collagen

Explanation

Tendon healing proceeds through three overlapping phases: inflammatory, proliferative (repair), and remodeling. During the early proliferative phase, fibroblasts primarily synthesize Type III collagen, which is disorganized, thinner, and mechanically weak. During the remodeling phase (which can last for months to years), this provisional Type III collagen matrix is gradually degraded and replaced by mature Type I collagen. The newly synthesized Type I collagen fibers orient longitudinally parallel to the axis of tension, which dramatically increases the tensile strength of the healed tendon.

Question 1673

Topic: Biology, Genetics & Bone Healing

A 70-year-old woman with severe osteoporosis and a recent vertebral compression fracture is started on romosozumab therapy. What is the primary mechanism of action of this medication at the cellular and molecular level?

. Inhibition of farnesyl pyrophosphate synthase in osteoclasts
. Binding to RANKL to prevent osteoclast activation and survival
. Monoclonal antibody binding to sclerostin, thereby enhancing Wnt/beta-catenin signaling
. Recombinant PTH analog that intermittently stimulates osteoblast activity
. Selective estrogen receptor modulation to decrease bone resorption

Correct Answer & Explanation

. Monoclonal antibody binding to sclerostin, thereby enhancing Wnt/beta-catenin signaling

Explanation

Romosozumab is a monoclonal antibody that targets and binds to sclerostin, a glycoprotein secreted by osteocytes. Sclerostin normally acts as an endogenous inhibitor of the Wnt/beta-catenin signaling pathway, which is crucial for osteoblast differentiation and bone formation. By inhibiting sclerostin, romosozumab enhances Wnt signaling, resulting in a dual effect: markedly increasing bone formation and moderately decreasing bone resorption.

Question 1674

Topic: Biology, Genetics & Bone Healing

A 45-year-old male sustains a midshaft tibial fracture and is treated with a dynamically locked intramedullary nail. The fracture gap is 2 mm. According to Perren's strain theory, what is the maximum interfragmentary strain that will still permit the direct formation of lamellar bone across the fracture gap?

. Less than 2%
. Between 2% and 10%
. Between 10% and 30%
. Between 30% and 50%
. Greater than 50%

Correct Answer & Explanation

. Less than 2%

Explanation

Perren's strain theory dictates that a specific tissue will only form in a fracture gap if the tissue can tolerate the strain (deformation) present. Lamellar bone is brittle and can only form under very low strain conditions (less than 2%). Woven bone can tolerate up to 10% strain, cartilage can tolerate between 10% and 30% strain, and granulation tissue can tolerate up to 100% strain. Absolute stability (strain < 2%) is required for primary (lamellar) bone healing.

Question 1675

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman with severe osteoporosis is treated with romosozumab to reduce her risk of fragility fractures. Which of the following best describes the molecular mechanism of action of this medication?

. Inhibition of the RANKL-RANK interaction
. Binding and inhibition of sclerostin
. Direct agonism of the parathyroid hormone (PTH) receptor
. Direct inhibition of the osteoclast ruffled border H+-ATPase
. Stimulation of endogenous osteoprotegerin (OPG) production

Correct Answer & Explanation

. Binding and inhibition of sclerostin

Explanation

Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin. Sclerostin is a glycoprotein produced primarily by osteocytes that naturally inhibits the Wnt/beta-catenin signaling pathway. By blocking sclerostin, romosozumab disinhibits the Wnt pathway, leading to increased osteoblast differentiation and bone formation, while also secondarily decreasing bone resorption.

Question 1676

Topic: Biology, Genetics & Bone Healing

A 68-year-old woman with a history of osteoporosis sustains a distal radius fracture. She has been on denosumab for 2 years prior to the injury. At the cellular and molecular level, how does this specific pharmacological agent primarily inhibit bone resorption?

. Binding directly to the ruffled border of mature osteoclasts to prevent acid secretion
. Inducing targeted apoptosis of mature osteoclasts by inhibiting farnesyl pyrophosphate synthase
. Binding to RANKL to prevent its interaction with the RANK receptor on osteoclast precursors
. Acting as a synthetic decoy receptor directly mimicking the action of osteoprotegerin (OPG) on RANK
. Inhibiting the differentiation of mesenchymal stem cells into the osteoclast lineage

Correct Answer & Explanation

. Binding to RANKL to prevent its interaction with the RANK receptor on osteoclast precursors

Explanation

Denosumab is a human monoclonal antibody that directly targets and binds to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents RANKL from interacting with the RANK receptor on the surface of osteoclast precursors and mature osteoclasts. This effectively halts osteoclastogenesis, decreases mature osteoclast function, and reduces survival. Bisphosphonates act by inhibiting farnesyl pyrophosphate synthase (nitrogenous) or inducing apoptosis. Osteoprotegerin (OPG) is the body's natural decoy receptor for RANKL; denosumab mimics the function of OPG but does not act on the RANK receptor itself.

Question 1677

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory regarding the biomechanics of fracture fixation, what is the maximum mechanical strain tolerated by lamellar bone tissue before it will fail to form across a fracture gap?

. 1%
. 2%
. 10%
. 30%
. 100%

Correct Answer & Explanation

. 1%

Explanation

Perren's strain theory dictates that the type of tissue that forms within a fracture gap is strictly determined by the local mechanical strain it can withstand without rupturing. Lamellar bone can only tolerate up to 2% strain. Therefore, absolute stability (strain < 2%) is required for primary bone healing. Woven bone tolerates up to 10% strain, cartilage up to 30%, and granulation tissue up to 100% strain.

Question 1678

Topic: Biology, Genetics & Bone Healing

A 45-year-old male sustains a closed, isolated midshaft tibia fracture and undergoes fixation with a dynamically locked intramedullary nail. Which of the following mechanical environments or systemic factors would most significantly upregulate the expression of Bone Morphogenetic Protein-2 (BMP-2) and promote the formation of a robust cartilaginous callus?

. Absolute rigid plate fixation with interfragmentary compression
. High-dose systemic nonsteroidal anti-inflammatory drug (NSAID) administration
. Controlled cyclic micromotion at the fracture site
. Systemic hyperbaric oxygen therapy
. Selective depletion of local inflammatory macrophages

Correct Answer & Explanation

. Controlled cyclic micromotion at the fracture site

Explanation

Secondary bone healing relies on endochondral ossification, characterized by the formation of a cartilaginous callus. This process is heavily mechanically driven by relative stability, which allows for controlled cyclic micromotion at the fracture site (e.g., dynamic intramedullary nailing, bridge plating, external fixation). This micromotion physically stimulates the upregulation of osteogenic factors, primarily BMP-2, driving chondrogenesis and callus formation. Absolute rigid fixation leads to primary bone healing without a callus. NSAIDs and macrophage depletion delay or inhibit fracture healing.

Question 1679

Topic: Biology, Genetics & Bone Healing

A 35-year-old man sustains a closed midshaft femur fracture and is treated with a locked intramedullary nail. Callus formation is noted on radiographs at 6 weeks. According to Perren's strain theory, what maximum level of interfragmentary strain allows for the formation of lamellar bone at the fracture site?

. Less than 2%
. 2% to 10%
. 10% to 30%
. 30% to 50%
. Greater than 50%

Correct Answer & Explanation

. 2% to 10%

Explanation

According to Perren's strain theory, the type of tissue that forms in a fracture gap depends on the interfragmentary strain. Lamellar bone is brittle and can only form when the strain is less than 2%. Woven bone can tolerate strains between 2% and 10%. Cartilage can tolerate strains up to approximately 10%, while granulation tissue can form and persist in high-strain environments up to 100%. Intramedullary nailing allows for secondary bone healing via callus formation by keeping strain in the optimal range.

Question 1680

Topic: Biology, Genetics & Bone Healing

Which of the following best describes the molecular mechanism of action of nitrogen-containing bisphosphonates (e.g., zoledronic acid) in the treatment of osteoporosis?

. Inhibition of RANKL binding to its receptor
. Inhibition of farnesyl pyrophosphate synthase
. Incorporation into ATP analogues leading to osteoclast apoptosis
. Stimulation of Wnt/beta-catenin signaling
. Inhibition of sclerostin

Correct Answer & Explanation

. Inhibition of farnesyl pyrophosphate synthase

Explanation

Nitrogen-containing bisphosphonates (such as alendronate, risedronate, and zoledronic acid) exert their effect by inhibiting farnesyl pyrophosphate synthase, an essential enzyme in the mevalonate pathway. This prevents the prenylation of small GTP-binding proteins (like Ras, Rho, and Rac), which are crucial for normal osteoclast function, ruffled border formation, and cell survival. Non-nitrogenous bisphosphonates (like etidronate) act differently by being incorporated into non-hydrolyzable ATP analogues, which ultimately induce osteoclast apoptosis. Denosumab inhibits RANKL, and romosozumab inhibits sclerostin.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page